Sam L Barker insider trades: Cyclacel Pharmaceuticals (CYCC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sam reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 30, 2021 | CYCC | ↓ Sell | 12 | $3.57 | $43 | Direct | Dec 2, 2021 (2d) |
| Aug 24, 2021 | CYCC | ↑ Buy | 1,000 | $5.00 | $5K | Direct | Aug 25, 2021 (1d) |
| Aug 2, 2019 | LXRX | ↑ Buy | 24,000 | $1.18 | $28K | Direct | Aug 2, 2019 (0d) |
| Sep 15, 2017 | LXRX | ↑ Buy | 1,000 | $12.50 | $13K | Direct | Sep 18, 2017 (3d) |
| Nov 20, 2014 | CYCC | ↑ Buy | 3,100 | $3.00 | $9K | Direct | Nov 20, 2014 (0d) |
| May 10, 2011 | CADX | ↑ Buy | 9,000 | $7.04 | $63K | Direct | May 11, 2011 (1d) |
| Oct 22, 2009 | LXRX | ↑ Buy | 19,000 | $1.56 | $30K | Direct | Oct 26, 2009 (4d) |
| Feb 4, 2009 | AGIX | ↓ Sell | 20,000 | $0.04 | $720 | by Trust | Feb 5, 2009 (1d) |
| Feb 4, 2009 | AGIX | ↓ Sell | 6,000 | $0.04 | $210 | Direct | Feb 5, 2009 (1d) |
| Apr 18, 2008 | LXRX | ↑ Buy | 40,000 | $1.96 | $79K | Direct | Apr 22, 2008 (4d) |
| Mar 17, 2008 | CADX | ↑ Buy | 5,000 | $5.26 | $26K | By the Judy A Barker 2008 GRAT Trust | Mar 19, 2008 (2d) |
| Mar 17, 2008 | CADX | ↑ Buy | 5,000 | $5.22 | $26K | By the Sam L Barker 2007 GRAT Trust | Mar 19, 2008 (2d) |
| Mar 17, 2008 | CADX | ↑ Buy | 1,000 | $5.37 | $5K | Direct | Mar 19, 2008 (2d) |
| Jan 25, 2008 | AGIX | ↑ Buy | 20,000 | $0.39 | $8K | by Trust | Feb 1, 2008 (7d) |
| Jan 25, 2008 | AGIX | ↑ Buy | 5,000 | $0.39 | $2K | Direct | Feb 1, 2008 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sam L Barker's insider trades
Sam L Barker is a director at Cyclacel Pharmaceuticals (CYCC). Since Jan 25, 2008, Sam has reported 12 open-market purchases worth $294K and 3 sales worth $973 on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (42 filings), option exercises (8 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYCC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.